Subscribe
tumsasedgars
tumsasedgars / iStockphoto.com
10 September 2018Americas

Amgen takes on Emcure over Sensipar generic

Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar (cinacalcet hydrochloride).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Amneal obtains non-infringement finding in Sensipar case
1 August 2018   Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride).
Americas
Generic Emcure stole COVID-19 vaccine trade secrets, lawsuit claims
22 March 2022   US pharma company HDT Bio has accused Emcure Pharmaceuticals of the “blatant theft” of its COVID-19 vaccine technology in a new lawsuit.
Big Pharma
Emcure says court should dismiss COVID vaccine secrets suit
17 May 2022   Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Amneal obtains non-infringement finding in Sensipar case
1 August 2018   Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride).
Americas
Generic Emcure stole COVID-19 vaccine trade secrets, lawsuit claims
22 March 2022   US pharma company HDT Bio has accused Emcure Pharmaceuticals of the “blatant theft” of its COVID-19 vaccine technology in a new lawsuit.
Big Pharma
Emcure says court should dismiss COVID vaccine secrets suit
17 May 2022   Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine.

More on this story

Americas
Amneal obtains non-infringement finding in Sensipar case
1 August 2018   Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride).
Americas
Generic Emcure stole COVID-19 vaccine trade secrets, lawsuit claims
22 March 2022   US pharma company HDT Bio has accused Emcure Pharmaceuticals of the “blatant theft” of its COVID-19 vaccine technology in a new lawsuit.
Big Pharma
Emcure says court should dismiss COVID vaccine secrets suit
17 May 2022   Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility